Literature DB >> 29685963

New chemical tools for probing activity and inhibition of the NAD+-dependent lysine deacylase sirtuin 2.

Sören Swyter1, Matthias Schiedel1,2, Daria Monaldi1, Sándor Szunyogh3, Attila Lehotzky3, Tobias Rumpf1,4, Judit Ovádi3, Wolfgang Sippl5, Manfred Jung6,7.   

Abstract

Sirtuins are NAD+-dependent protein deacylases capable of cleaving off acetyl as well as other acyl groups from the ɛ-amino group of lysines in histones and other substrate proteins. They have been reported as promising drug targets, and thus modulators of their activity are needed as molecular tools to uncover their biological function and as potential therapeutics. Here, we present new assay formats that complement existing assays for sirtuin biochemistry and cellular target engagement. Firstly, we report the development of a homogeneous fluorescence-based activity assay using unlabelled acylated peptides. Upon deacylation, the free lysine residue reacts with fluorescamine to form a fluorophore. Secondly, using click chemistry with a TAMRA-azide on a propargylated sirtuin inhibitor, we prepared the first fluorescently labelled small-molecule inhibitor of Sirt2. This is used in a binding assay, which is based on fluorescence polarization. We used it successfully to map potential inhibitor-binding sites and also to show cellular Sirt2 engagement. By means of these new assays, we were able to identify and characterize novel Sirt2 inhibitors out of a focused library screen. The binding of the identified Sirt2 inhibitors was rationalized by molecular docking studies. These new chemical tools thus can enhance further sirtuin research.This article is part of a discussion meeting issue 'Frontiers in epigenetic chemical biology'.
© 2018 The Author(s).

Entities:  

Keywords:  NAD+; Sirt2; assays; deacetylases; epigenetics; sirtuins

Mesh:

Substances:

Year:  2018        PMID: 29685963      PMCID: PMC5915722          DOI: 10.1098/rstb.2017.0083

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  73 in total

1.  SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

Authors:  Barrie Peck; Chun-Yuan Chen; Ka-Kei Ho; Paolo Di Fruscia; Stephen S Myatt; R Charles Coombes; Matthew J Fuchter; Chwan-Deng Hsiao; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

2.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

3.  The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

Authors:  Teresa Faria Pais; Éva M Szegő; Oldriska Marques; Leonor Miller-Fleming; Pedro Antas; Patrícia Guerreiro; Rita Machado de Oliveira; Burcu Kasapoglu; Tiago Fleming Outeiro
Journal:  EMBO J       Date:  2013-09-06       Impact factor: 11.598

4.  Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins.

Authors:  Jessica L Feldman; Josue Baeza; John M Denu
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

Review 5.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

6.  Mechanism of human SIRT1 activation by resveratrol.

Authors:  Margie T Borra; Brian C Smith; John M Denu
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

7.  An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3.

Authors:  Ying-Ling Chiang; Hening Lin
Journal:  Org Biomol Chem       Date:  2016-01-21       Impact factor: 3.876

8.  Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism.

Authors:  Melanie Gertz; Frank Fischer; Giang Thi Tuyet Nguyen; Mahadevan Lakshminarasimhan; Mike Schutkowski; Michael Weyand; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

9.  Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.

Authors:  Jintang Du; Yeyun Zhou; Xiaoyang Su; Jiu Jiu Yu; Saba Khan; Hong Jiang; Jungwoo Kim; Jimin Woo; Jun Huyn Kim; Brian Hyun Choi; Bin He; Wei Chen; Sheng Zhang; Richard A Cerione; Johan Auwerx; Quan Hao; Hening Lin
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

10.  SIRT2 as a Therapeutic Target for Age-Related Disorders.

Authors:  Rita Machado de Oliveira; Jana Sarkander; Aleksey G Kazantsev; Tiago Fleming Outeiro
Journal:  Front Pharmacol       Date:  2012-05-03       Impact factor: 5.810

View more
  13 in total

Review 1.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

2.  Epigenetics: the first 25 centuries.

Authors:  A Ganesan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 3.  Sirtuin modulators: past, present, and future perspectives.

Authors:  Francesco Fiorentino; Nicola Mautone; Martina Menna; Francesca D'Acunzo; Antonello Mai; Dante Rotili
Journal:  Future Med Chem       Date:  2022-05-18       Impact factor: 4.767

4.  Azologization and repurposing of a hetero-stilbene-based kinase inhibitor: towards the design of photoswitchable sirtuin inhibitors.

Authors:  Christoph W Grathwol; Nathalie Wössner; Sören Swyter; Adam C Smith; Enrico Tapavicza; Robert K Hofstetter; Anja Bodtke; Manfred Jung; Andreas Link
Journal:  Beilstein J Org Chem       Date:  2019-09-16       Impact factor: 2.883

5.  Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases.

Authors:  Nathalie Wössner; Zayan Alhalabi; Jessica González; Sören Swyter; Jin Gan; Karin Schmidtkunz; Lin Zhang; Alejandro Vaquero; Huib Ovaa; Oliver Einsle; Wolfgang Sippl; Manfred Jung
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

6.  Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility.

Authors:  Christoph W Grathwol; Nathalie Wössner; Steven Behnisch-Cornwell; Lukas Schulig; Lin Zhang; Oliver Einsle; Manfred Jung; Andreas Link
Journal:  ChemMedChem       Date:  2020-05-07       Impact factor: 3.466

7.  Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors.

Authors:  Steven Behnisch-Cornwell; Christoph W Grathwol; Lukas Schulig; Anika Voigt; Daniel Baecker; Andreas Link; Patrick J Bednarski
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 8.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

9.  HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.

Authors:  Matthias Schiedel; Attila Lehotzky; Sandor Szunyogh; Judit Oláh; Sören Hammelmann; Nathalie Wössner; Dina Robaa; Oliver Einsle; Wolfgang Sippl; Judit Ovádi; Manfred Jung
Journal:  Chembiochem       Date:  2020-08-27       Impact factor: 3.164

10.  Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.

Authors:  Tianling Ding; Jie Hao
Journal:  Mol Med Rep       Date:  2021-09-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.